Inhaled Corticosteroids and Long-Acting β2 Receptor Agonists for Preterm-Born Children-New Insights but Still Many Questions-Reply

Affiliations

¹ North Wales Organisation for Randomised Trials in Health, Bangor University, Bangor, United Kingdom.
² Department of Paediatrics, Cardiff and Vale University Health Board, Cardiff, United Kingdom.
³ Department of Child Health, Cardiff University School of Medicine, Cardiff, United Kingdom.

Comment

Nia Goulden et al. JAMA Pediatr. 2022.

. 2022 Jun 1;176(6):615-616.

doi: 10.1001/jamapediatrics.2022.0300.

¹ North Wales Organisation for Randomised Trials in Health, Bangor University, Bangor, United Kingdom.
² Department of Paediatrics, Cardiff and Vale University Health Board, Cardiff, United Kingdom.
³ Department of Child Health, Cardiff University School of Medicine, Cardiff, United Kingdom.

No abstract available

Comment on

Inhaled Corticosteroids Alone and in Combination With Long-Acting β2 Receptor Agonists to Treat Reduced Lung Function in Preterm-Born Children: A Randomized Clinical Trial.
Goulden N, Cousins M, Hart K, Jenkins A, Willetts G, Yendle L, Doull I, Williams EM, Hoare Z, Kotecha S. Goulden N, et al. JAMA Pediatr. 2022 Feb 1;176(2):133-141. doi: 10.1001/jamapediatrics.2021.5111. JAMA Pediatr. 2022. PMID: 34902004 Free PMC article. Clinical Trial.
Inhaled Corticosteroids and Long-Acting β2 Receptor Agonists for Preterm-Born Children-New Insights but Still Many Questions.
Bonadies L, Moschino L, Baraldi E. Bonadies L, et al. JAMA Pediatr. 2022 Jun 1;176(6):614-615. doi: 10.1001/jamapediatrics.2022.0303. JAMA Pediatr. 2022. PMID: 35377410 No abstract available.